Kristen R. Scarpato, MD, MPH

Kristen R. Scarpato, MD, MPH, discusses the potential role of emerging immunotherapy-based combinations in the treatment of BCG-naive, high-risk non–muscle invasive bladder cancer.

Kristen R. Scarpato, MD, MPH, recaps a panel discussion at SWIU 2026 focused on imposter syndrome.

Kristen R. Scarpato, MD, MPH, discusses what level of evidence is necessary to shift the standard of care in BCG-naive NMIBC.

Benefits include improved quality of life and symptom management.

Advances allow for more accurate detection of metastatic disease.

Renal mass biopsy should be used for patients in whom results would impact management decisions.